test

Raymond Debbane

@Siren, L.l.c.

Latest period2024 - Q3ReportedManaged Assets$2BTotal holdings110
Assets growth rate0%Assets growth rate (2-Q avg)0%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Siren, L.l.c.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 110 positions.

Assets under management

The assets under management (AUM) of Siren, L.l.c. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2B in assets, with a quarterly growth rate of 0% and a 2-quarter average growth rate of 0%. The portfolio is managed by Raymond Debbane, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
KYMRKymera Therapeutics Inc
Recent Activity
New Position
7.03%
$140.557M
2.97M shares@ $47.34 avg price
BGNEBeigene Ltd
Recent Activity
New Position
6.33%
$126.47M
563,314 shares@ $224.51 avg price
SRRKScholar Rock Holding Corp
Recent Activity
New Position
4.51%
$90.188M
11.259M shares@ $8.01 avg price
BCAXBicara Therapeutics Inc
Recent Activity
New Position
3.92%
$78.265M
3.073M shares@ $25.48 avg price
ARGXArgenx Se
Recent Activity
New Position
3.9%
$77.868M
143,647 shares@ $542.09 avg price
CRNXCrinetics Pharmaceuticals Inc
Recent Activity
New Position
3.35%
$66.923M
1.31M shares@ $51.1 avg price
RNAAvidity Biosciences Inc
Recent Activity
New Position
3.31%
$66.173M
1.441M shares@ $45.93 avg price
APLSApellis Pharmaceuticals Inc
Recent Activity
New Position
3.13%
$62.503M
2.167M shares@ $28.84 avg price
LXRXLexicon Pharmaceuticals Inc
Recent Activity
New Position
3.06%
$61.103M
38.919M shares@ $1.58 avg price
IGMSIgm Biosciences Inc
Recent Activity
New Position
2.76%
$55.085M
3.33M shares@ $16.55 avg price